Analysis of Therapeutic Effects and Prognostic Factors for Hepatic Metastasis from Gastric Cancer

GUAN Yu,LIU Zhan-bing,WANG Xin,LIU Yu-cun,CHEN Guo-wei

DOI: https://doi.org/10.11855/j.issn.0577-7402.2016.04.10

2016-01-01

Abstract:Objective To investigate the effects of therapeutic methods and clinicopathologic factors on the prognosis of patients with hepatic metastasis from gastric carcinoma (GCHM). Methods Clinical data of 136 GCHM cases in Peking University First Hospital, consisting of 48 cases undergoing chemotherapy, 45 cases undergoing interventional therapy and 43 cases undergoing hepatectomy, were reviewed from Jan. 2003 to Jan. 2013. The clinicopathologic parameters were analyzed with univariate and multivariate Cox regression model and Kaplan-Meier method. Results The median survival time of chemotherapy group, interventional group and surgical group were 8.7, 10.1 and 13.3 months. Univariate analysis showed the presentation (P=0.009), the classification (P=0.001) and the maximum diameter (P=0.001) of hepatic metastatic tumor, the T (P=0.020) and the N (P=0.006) stage of primary tumor, and the therapeutic methods (P=0.002) were statistically significant with the prognosis. Multivariate analysis indicated that the classification (P=0.018), the maximum diameter (P=0.001) of hepatic metastasis, the N stage of the primary tumor (P=0.008) and the therapeutic methods (P=0.041) were independent prognostic factors. Conclusions The combination of surgical therapy with systemic or regional therapy towards GCHM may be a promising strategy for prolonging survival. The classification and maximum diameter of hepatic metastasis and primary tumor N stage are considered as the independent prognostic factors of GCHM. DOI: 10.11855/j.issn.0577-7402.2016.04.10